CD44 and neoplasm: Cytoplasmic CD74 expressed on APCs functions as an antigen-presenting partner, whereas the overexpression of cell surface CD74 on tumor cells or immune cells serves as MIF receptor, promoting the release of pro-inflammatory and pro-angiogenic factors along with CD44 and CXCR4 ligands [47].